We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Purdue Pharma agreed on Tuesday to pay about $270 million to Oklahoma to resolve allegations that the drugmaker fuelled the opioid crisis through its aggressive marketing of OxyContin (oxycodone).